Cite
HARVARD Citation
Batticciotto, A. et al. (2016). Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate. Advances in therapy. 33 (8), pp. 1360-1373. [Online].